TACT2 – The Second Trial to Assess Chelation Therapy

While our clinical focus at the Seekers Centre is on treating pain and healing the brain, we are proud to be enrolling patients in this landmark clinical trial. In the first TACT trial, chelation therapy led to a 50% reduction in heart-related deaths in people with diabetes.  If TACT2 replicates these findings, it would make chelation therapy more important than any other treatment for this epidemic disease.

 

The BEAM Project

Bringing Evidence to Alternative Medicine.
There are many non-drug treatments available today that have the potential to improve healthcare. These have been sometimes described in the research literature as ‘alternative medicine’. Integrative medicine is a patient-cantered approach to healthcare that includes many of these so-called Complementary and Alternative Medicine (CAM) therapies.